Paper Warns on Duplicate Discounts from 340B Ceiling Price, Medicare Maximum Price

An Avalere study suggested 340B duplicate discounts could increase as a result of Medicare drug price negotiations.
Timelines for manufacturers to provide new Medicare “maximum fair prices” (MFPs) and 340B ceiling prices on drugs are misaligned, risking [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

In Study, Health Center’s Patients Laud its 340B Drug Assistance Program

A recent study suggested a 340B cash discount program was associated with better outcomes for patients with diabetes.
A recent study found positive patient benefits from a 340B cash discount program. Low-income patients said saving money on injectable [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HHS and HRSA Urge Judge to Reject Health Center’s Take on 340B Patient Definition

Genesis Health Care building and signage
Genesis Health Care's proposed 340B patient definition would remove all limits on dispensing 340B drugs, HHS and HRSA told a federal district judge.
Federal healthcare agencies recently told a federal district judge that backing a South Carolina health center’s interpretation of the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital Fighting 340B Expulsion Gets Temporary Reprieve

Insight Hospital and Medical Center Chicago has an additional 31 days to fight its expulsion from the 340B program, a federal district judge ordered.
A federal district judge has granted a Chicago hospital an additional 31 days to fight its expulsion from the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

BMS Expands 340B Contract Pharmacy Conditions, Including for Grantees

Bristol Myers Squibb
Bristol Myers Squibb has announced updates to its conditions on pharmaceutical sales involving contract pharmacies.
Bristol Myers Squibb (BMS) announced updates to its conditions on pharmaceutical sales involving contract pharmacies, effective Nov. 1. BMS outlined [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital Sues to Stop 340B Expulsion Over Alleged Failure to Recertify

The hospital Insight Chicago and federal regulators have agreed to dismiss a case before a federal district court over the hospital's 340B eligibility.
A federal district judge is temporarily keeping an inner-city Chicago hospital in the 340B program as it fights to prevent [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novartis Offering 340B Refunds on Two Diagnostic Radiopharmaceuticals

Novartis wordmark on a building
Drugmaker Novartis is offering refunds to 340B covered entities on certain purchases of two radiopharmaceuticals.
Drug manufacturer Novartis is offering 340B covered entities refunds on purchases of two imaging agents, partly contingent on whether an [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Eisai Adopts 340B Contract Pharmacy Restrictions, Pfizer and GSK Update Their Limits

Eisai contract pharmacy
Drugmaker Eisai's 340B hospital contract pharmacy restrictions will not apply to Arkansas and Louisiana providers.
Japanese pharmaceutical manufacturer Eisai will restrict 340B pricing on six drugs when dispensed by hospitals’ contract pharmacies. It is the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

In Key 340B Patient Definition Case, Hospital Group Accuses Drugmakers of “Numerous Misstatements”

SC district court
Chief Judge R. Bryan Harwell of the U.S. District Court for the District of South Carolina has not yet decided on 340B Health's request to file an amicus brief in a key 340B patient definition case.
A national hospital group has asked a federal district court for permission “to correct numerous misstatements” that it says drug [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Lilly and Novo Post 340B Refund Notices, Amgen Posts 340B Replenishment Notice

Eli Lily and Novo Nordisk
Lilly and Novo Nordisk are refunding 340B covered entities on some products due to 340B ceiling price adjustments.
Drugmakers Lilly and Novo Nordisk are giving covered entities refunds on some products due to 340B ceiling price adjustments, according [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »